(19)
(11) EP 2 493 917 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2020 Bulletin 2020/10

(45) Mention of the grant of the patent:
11.12.2019 Bulletin 2019/50

(21) Application number: 10787709.4

(22) Date of filing: 26.10.2010
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
G01N 33/574(2006.01)
 G01N 33/50(2006.01)
(86) International application number:
PCT/EP2010/066146
(87) International publication number:
WO 2011/051277 (05.05.2011 Gazette 2011/18)

(54)

BREAST TUMOR MARKERS AND METHODS OF USE THEREOF

BRUSTTUMORMARKER UND DEREN VERWENDUNG

MARQUERS DE LA TUMEUR DU SEIN ET LEUR UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.10.2009 EP 09174060

(43) Date of publication of application:
05.09.2012 Bulletin 2012/36

(60) Divisional application:
17209384.1 / 3345920

(73) Proprietor: EXTERNAUTICS SOCIETA' A RESPONSABILITA' LIMITATA "SOCIETA' IN LIQUIDAZIONE"
53100 Siena (IT)

(72) Inventors:
  • GRIFANTINI, Renata
    53100 Siena (IT)
  • PILERI, Piero
    53100 Siena (IT)
  • CAMPAGNOLI, Susanna
    53100 Siena (IT)
  • GRANDI, Alberto
    53100 Siena (IT)
  • PARRI, Matteo
    53100 Siena (IT)
  • PIERLEONI, Andrea
    53100 Siena (IT)
  • NOGAROTTO, Renzo
    53100 Siena (IT)

(74) Representative: Banfi, Paolo 
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano
20129 Milano (IT)


(56) References cited: : 
WO-A2-2007/109376
 US-A1- 2006 204 503
   
  • GARCIA-RUDAZ CECILIA ET AL: "Fxna, a novel gene differentially expressed in the rat ovary at the time of folliculogenesis, is required for normal ovarian histogenesis." DEVELOPMENT (CAMBRIDGE, ENGLAND) MAR 2007 LNKD- PUBMED:17267443, vol. 134, no. 5, March 2007 (2007-03), pages 945-957, XP002618324 ISSN: 0950-1991
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).